Pédiatrie Tumeurs solides MK-7902-013 A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080) (E7080-G000-231) Paris ISABELLE AERTS
Appareil pulmonaire NIVOTHYM (EORTC-1525) Single-arm, Multicentre, Phase II Study of Immunotherapy in Patients With Type B3 Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy Paris NICOLAS GIRARD
Appareil pulmonaire SAVANNAH (D5084C00007) Phase II, Single Arm Study Assessing the Efficacy of Osimertinib in;Combination with Savolitinib in Patients with EGFRm+ and MET+, Locally;Advanced or Metastatic Non-Small Cell Lung Cancer who have Progressed;Following Treatment with Osimertinib (The SAVANNAH Study) Paris NICOLAS GIRARD
Appareil pulmonaire SKYSCRAPER-06 (BO42592) A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Patients With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer. Paris
Appareil pulmonaire HERTHENA-Lung01 U31402-A-U201 HERTHENA-Lung01: A Phase 2 Randomized Open-Label;Study of Patritumab Deruxtecan (U3-1402) in Subjects with;Previously Treated Metastatic or Locally Advanced EGFRmutated;Non-Small Cell Lung Cancer (NSCLC) Paris NICOLAS GIRARD
Appareil pulmonaire TROPION-Lung05 (DS1062-A-U202) Phase 2, Single-arm, Open-label Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations and Progressed on or After Kinase Inhibitor Therapy and Platinum Based Chemotherapy (TROPION-Lung05) Paris NICOLAS GIRARD
Appareil pulmonaire TAS6417-201 An Open-Label, Phase 2b, Global Multicenter Cohort Trial to;Assess the Safety and Efficacy of Zipalertinib in Patients;with Locally Advanced or Metastatic Non-Small Cell Lung;Cancer with Exon 20 Insertion and Uncommon/Single or;Compound Epidermal Growth Factor Receptor Mutations. Paris NICOLAS GIRARD
Appareil pulmonaire DS 73001-003 A PHASE 2, MULTICENTER, RANDOMIZED, OPENLABEL;STUDY OF DS-7300A, A B7-H3 ANTIBODY;DRUG CONJUGATE (ADC), IN SUBJECTS WITH;PRETREATED EXTENSIVE-STAGE SMALL CELL;LUNG CANCER (ES-SCLC). Paris PAULINE DU RUSQUEC
Sein métastatique triple négatif TOPOLOGY A phase II study to evaluate the efficacy and toxicities;of PLX038, in patients with locally advanced or metastatic triple-negative breast cancer. Paris, Saint-Cloud FRANCOIS-CLEMENT BIDARD, FRANCOIS-CLEMENT BIDARD
Appareil pulmonaire ENCO-BRAF (IFCT-1904) A Phase II Study of the BRAF Inhibitor Encorafenib in Combination With the MEK Inhibitor Binimetinib in Patients With BRAFV600E-mutant Metastatic Non-small Cell Lung Cancer Paris